Nyctalopin Protein (NYX) (Myc-DYKDDDDK Tag)
NYX
宿主: 人
宿主: HEK-293 Cells
Recombinant
> 80 % as determined by SDS-PAGE and Coomassie blue staining
AbP, STD
1 image
-
- 抗原 See all Nyctalopin (NYX) 蛋白
- Nyctalopin (NYX)
- 蛋白类型
- Recombinant
- 宿主
- 人
- 资源
- HEK-293 Cells
- 标记
- This Nyctalopin protein is labelled with Myc-DYKDDDDK Tag.
- 应用范围
- Antibody Production (AbP), Standard (STD)
- 产品特性
-
- Recombinant human Nyctalopin protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- 纯度
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
-
- 应用备注
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - 说明
-
The tag is located at the C-terminal.
- 限制
- 仅限研究用
-
- 浓度
- 50 μg/mL
- 缓冲液
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- 储存条件
- -80 °C
- 储存方法
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- 抗原
- Nyctalopin (NYX)
- 别名
- Nyctalopin (NYX 产品)
- 别名
- MGC84276 Protein, CLRP Protein, CSNB1 Protein, CSNB1A Protein, CSNB4 Protein, NBM1 Protein, CLNP Protein, nob Protein, RGD1561300 Protein, nyctalopin Protein, nyctalopin L homeolog Protein, uncharacterized LOC491837 Protein, NYX Protein, nyx.L Protein, LOC491837 Protein, nyx Protein, Nyx Protein
- 背景
- The product of this gene belongs to the small leucine-rich proteoglycan (SLRP) family of proteins. Defects in this gene are the cause of congenital stationary night blindness type 1 (CSNB1), also called X-linked congenital stationary night blindness (XLCSNB). CSNB1 is a rare inherited retinal disorder characterized by impaired scotopic vision, myopia, hyperopia, nystagmus and reduced visual acuity. The role of other SLRP proteins suggests that mutations in this gene disrupt developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB.
- 分子量
- 49.5 kDa
- NCBI登录号
- NP_072089
-
You are here:
